跳至主要内容
临床试验/EUCTR2014-004522-17-GB
EUCTR2014-004522-17-GB进行中(未招募)不适用

The mechanism of action of N-ACetylcysteine for reducing the risk of Infection in Alcoholic Hepatitis - NACAH Version 1.1

Imperial College London & Imperial College Healthcare NHS Trust0 个研究点目标入组 42 人开始时间: 2015年1月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Aged 18 to 75 years
  • Clinical alcoholic hepatitis:
  • oSerum bilirubin >80umol/L
  • oHistory of alcohol excess (>80g/day male, >60g/day female)
  • oLess than 4 weeks since admission to hospital
  • oInformed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 38
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 4

排除标准

  • Alcohol abstinence of >6 weeks prior to randomisation
  • Duration of jaundice >3 months
  • Other causes of liver disease including:
  • oEvidence of viral hepatitis (hepatitis B or C)
  • oBiliary obstruction
  • oHepatocellular carcinoma
  • Evidence of current malignancy (except non-melanotic skin cancer)
  • Previous entry into the study,
  • Patients with known hypersensitivity or previous anaphylactoid reactions to NAC
  • Pregnant or lactating women

研究者

发起方
Imperial College London & Imperial College Healthcare NHS Trust

相似试验